Intuniv (guanfacine) withdrawal symptoms typically begin within 2 to 3 days after the last dose and resolve within about a week for most people, though blood pressure and heart rate changes can sometimes persist for up to 2 weeks. The timeline depends heavily on whether you stop abruptly or taper gradually, and abrupt discontinuation carries real cardiovascular risks.
What Withdrawal Feels Like
Intuniv works by calming the sympathetic nervous system, the part of your body responsible for the “fight or flight” response. It lowers heart rate, reduces blood pressure, and quiets certain stress signals in the brain. When you stop taking it, that calming effect lifts and your nervous system rebounds, sometimes overshooting back to a more activated state than where you started.
The most common withdrawal symptoms include increased heart rate, elevated blood pressure, and headaches. In clinical studies, four out of five patients reported headaches starting from the second day after stopping the medication. Other reported symptoms include nervousness, agitation, tremors, confusion, fatigue, abdominal pain, and increased appetite. Children may also experience leg pain and unusual tiredness.
Day-by-Day Withdrawal Timeline
Research tracking patients after abrupt discontinuation shows a fairly predictable pattern. Blood pressure begins climbing gradually over the first 2 to 4 days. Stress hormones in the blood return to pre-treatment levels by day 3 and can actually exceed normal levels by day 4, which is when symptoms tend to peak.
For most people, the acute phase resolves within the first week. The drug’s blood pressure-lowering effect wears off over roughly 2 to 3 days, which is slower than similar medications like clonidine. This slower offset is actually somewhat protective: it gives your body more time to adjust, which is why severe rebound reactions are less common with guanfacine than with clonidine.
That said, Health Canada’s product monograph warns that withdrawal symptoms “may occur within a few days or after a few weeks.” So while most people are through the worst of it in under a week, some experience lingering blood pressure elevation or intermittent symptoms for 1 to 2 weeks after their last dose.
Why Abrupt Stopping Is Risky
The biggest concern with stopping Intuniv suddenly is rebound hypertension, a spike in blood pressure that overshoots your baseline. This happens because your nervous system has adapted to the drug’s calming effect. Remove the drug quickly and the system fires harder than it would have before you ever started taking it.
In rare cases, this rebound can become severe enough to cause hypertensive encephalopathy, a dangerous condition where extremely high blood pressure affects brain function. Symptoms include severe headache, confusion, and changes in mental status. At least one pediatric case has been documented in the medical literature. This is uncommon, but it’s the reason prescribers insist on gradual tapering rather than cold-turkey discontinuation.
The Recommended Taper Schedule
The standard guidance is to reduce your dose by no more than 1 mg every 3 to 7 days. So if you’re taking 4 mg daily, a typical taper might look like dropping to 3 mg for a week, then 2 mg for a week, then 1 mg for a week before stopping entirely. The whole process takes roughly 3 to 4 weeks depending on your starting dose.
A proper taper dramatically reduces the severity of withdrawal symptoms. Instead of your nervous system experiencing a sudden loss of the drug’s calming effect, it gets small, manageable adjustments that allow it to recalibrate gradually. Some people still notice mild symptoms at each dose reduction, particularly a slight uptick in heart rate or a return of restlessness, but these are typically far milder than what occurs with abrupt discontinuation.
Withdrawal in Children and Teens
Most Intuniv prescriptions are written for children and adolescents with ADHD, which makes pediatric withdrawal a practical concern for many families. The same cardiovascular risks apply to younger patients: rebound increases in blood pressure and heart rate can occur, and the FDA’s safety review flags these as key monitoring points during discontinuation.
Children may not articulate what they’re feeling as clearly as adults. Watch for signs like increased irritability, complaints of headache, unusual fatigue, stomach pain, or leg discomfort. An FDA safety review noted one pediatric case involving fatigue, leg and abdominal pain, and increased appetite after discontinuation. If your child seems unusually agitated, confused, or complains of a severe headache during the tapering process, that warrants prompt medical attention, as these can be signs of a dangerous blood pressure spike.
What to Monitor During Discontinuation
Blood pressure and heart rate are the two numbers that matter most during Intuniv withdrawal. If you have a home blood pressure monitor, checking once or twice daily during the taper and for at least a week after the final dose gives you a reliable safety net. You’re looking for readings that stay reasonably close to your normal baseline. A modest rise is expected and not dangerous, but a sharp or sustained jump, especially combined with headache or confusion, is a red flag.
If you were taking Intuniv for ADHD rather than blood pressure, you’ll also likely notice a return of the symptoms the medication was managing. Increased restlessness, difficulty focusing, and impulsivity often re-emerge during or shortly after the taper. These aren’t withdrawal effects per se; they’re the underlying ADHD symptoms coming back. Distinguishing between “my ADHD is returning” and “I’m experiencing cardiovascular withdrawal” is worth keeping in mind, since the former is expected and the latter requires monitoring.